These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 21868287)

  • 1. Optimizing dosage to prevent emergence of resistance - lessons from in vitro models.
    Singh R; Tam VH
    Curr Opin Pharmacol; 2011 Oct; 11(5):453-6. PubMed ID: 21868287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimizing drug exposure to minimize selection of antibiotic resistance.
    Olofsson SK; Cars O
    Clin Infect Dis; 2007 Sep; 45 Suppl 2():S129-36. PubMed ID: 17683017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A network-based approach for resistance transmission in bacterial populations.
    Gehring R; Schumm P; Youssef M; Scoglio C
    J Theor Biol; 2010 Jan; 262(1):97-106. PubMed ID: 19747924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antimicrobial drug use and resistance among respiratory pathogens in the community.
    Low DE
    Clin Infect Dis; 2001 Sep; 33 Suppl 3():S206-13. PubMed ID: 11524720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emergence and spread of antibiotic resistance following exposure to antibiotics.
    Cantón R; Morosini MI
    FEMS Microbiol Rev; 2011 Sep; 35(5):977-91. PubMed ID: 21722146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antimicrobial drug resistance.
    Martinez M; Silley P
    Handb Exp Pharmacol; 2010; (199):227-64. PubMed ID: 20204590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interpreting culture and susceptibility data in critical care: perks and pitfalls.
    Boothe DM
    J Vet Emerg Crit Care (San Antonio); 2010 Feb; 20(1):110-31. PubMed ID: 20230440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics and pharmacodynamics in antibiotic dose optimization.
    Sy SK; Zhuang L; Derendorf H
    Expert Opin Drug Metab Toxicol; 2016; 12(1):93-114. PubMed ID: 26652832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of once-, twice- and thrice-daily dosing of colistin on antibacterial effect and emergence of resistance: studies with Pseudomonas aeruginosa in an in vitro pharmacodynamic model.
    Bergen PJ; Li J; Nation RL; Turnidge JD; Coulthard K; Milne RW
    J Antimicrob Chemother; 2008 Mar; 61(3):636-42. PubMed ID: 18227094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacodynamics: relation to antimicrobial resistance.
    Rybak MJ
    Am J Infect Control; 2006 Jun; 34(5 Suppl 1):S38-45; discussion S64-73. PubMed ID: 16813981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibiotic exposure as a risk factor for emergence of resistance: the influence of concentration.
    Gould IM; MacKenzie FM
    Symp Ser Soc Appl Microbiol; 2002; (31):78S-84S. PubMed ID: 12481832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antimicrobial resistance.
    Clarke CR
    Vet Clin North Am Small Anim Pract; 2006 Sep; 36(5):987-1001, vi. PubMed ID: 16984824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The effect of antimicrobial use on emergence and selection of resistance].
    Harbarth S
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2007 Feb; 42(2):130-5. PubMed ID: 17309021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mathematical modelling response of Pseudomonas aeruginosa to meropenem.
    Tam VH; Schilling AN; Poole K; Nikolaou M
    J Antimicrob Chemother; 2007 Dec; 60(6):1302-9. PubMed ID: 17913722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [PK/PD of antimicrobials].
    Totsuka K
    Nihon Rinsho; 2007 Feb; 65 Suppl 2 Pt. 1():311-4. PubMed ID: 17455637
    [No Abstract]   [Full Text] [Related]  

  • 16. In nosocomial pneumonia, optimizing antibiotics other than aminoglycosides is a more important determinant of successful clinical outcome, and a better means of avoiding resistance.
    Schentag JJ; Birmingham MC; Paladino JA; Carr JR; Hyatt JM; Forrest A; Zimmer GS; Adelman MH; Cumbo TJ
    Semin Respir Infect; 1997 Dec; 12(4):278-93. PubMed ID: 9436955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The importance of appropriate antimicrobial dosing: pharmacokinetic and pharmacodynamic considerations.
    Preston SL
    Ann Pharmacother; 2004 Sep; 38(9 Suppl):S14-8. PubMed ID: 15226489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetic/pharmacodynamic relationships of antimicrobial drugs used in veterinary medicine.
    McKellar QA; Sanchez Bruni SF; Jones DG
    J Vet Pharmacol Ther; 2004 Dec; 27(6):503-14. PubMed ID: 15601444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacodynamics of antimicrobial drugs.
    Levison ME
    Infect Dis Clin North Am; 2004 Sep; 18(3):451-65, vii. PubMed ID: 15308272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New concepts in antimicrobial susceptibility testing: the mutant prevention concentration and mutant selection window approach.
    Blondeau JM
    Vet Dermatol; 2009 Oct; 20(5-6):383-96. PubMed ID: 20178475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.